These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 12607404)

  • 21. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
    Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
    Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined detection of CEA, CK-19 and c-met mRNAs in peripheral blood: a highly sensitive panel for potential molecular diagnosis of non-small cell lung cancer.
    Sheu CC; Chang MY; Chang HC; Tsai JR; Lin SR; Chang SJ; Hwang JJ; Huang MS; Chong IW
    Oncology; 2006; 70(3):203-11. PubMed ID: 16809939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response.
    Rüttinger D; van den Engel NK; Winter H; Schlemmer M; Pohla H; Grützner S; Wagner B; Schendel DJ; Fox BA; Jauch KW; Hatz RA
    J Transl Med; 2007 Sep; 5():43. PubMed ID: 17868452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat-induced radial segmentation of leucocyte nuclei: a non-specific phenomenon accompanying inflammatory and necrotizing diseases.
    Neftel KA; Müller OM
    Br J Haematol; 1981 Jul; 48(3):377-82. PubMed ID: 7259988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro exposure of NK-92 cells to serum from patients with non-small cell lung cancer impairs their cytotoxicity.
    Tsartsalis D; Grapsa D; Skopeliti M; Dragioti E; Charpidou A; Politi E; Tsitsilonis O; Syrigos K
    Anticancer Res; 2015 Mar; 35(3):1543-8. PubMed ID: 25750309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAM28 is a serological and histochemical marker for non-small-cell lung cancers.
    Kuroda H; Mochizuki S; Shimoda M; Chijiiwa M; Kamiya K; Izumi Y; Watanabe M; Horinouchi H; Kawamura M; Kobayashi K; Okada Y
    Int J Cancer; 2010 Oct; 127(8):1844-56. PubMed ID: 20112342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of hRad9 protein in the nuclei of nonsmall cell lung carcinoma cells.
    Maniwa Y; Yoshimura M; Bermudez VP; Yuki T; Okada K; Kanomata N; Ohbayashi C; Hayashi Y; Hurwitz J; Okita Y
    Cancer; 2005 Jan; 103(1):126-32. PubMed ID: 15558813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous and oxalate-induced radial segmentation of the nuclei of lymphocytes from peripheral blood from patients with chronic lymphocytic leukaemia.
    Valmin K
    Scand J Haematol; 1976 Jul; 17(1):53-6. PubMed ID: 959774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vascular endothelial growth factor in non‑small cell lung cancer pathogenesis.
    Krupnova EV; Shapetska MN; Mikhalenko EP; Chebotaryova NV; Shchayuk AN; Pissarchik SN; Prokhorov AV
    Exp Oncol; 2015 Sep; 37(3):213-7. PubMed ID: 26422107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
    Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
    Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
    Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
    Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
    Tsao SM; Yin MC; Liu WH
    Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.
    Hofman V; Long E; Ilie M; Bonnetaud C; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Marquette CH; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Vielh P; Hofman P
    Cytopathology; 2012 Feb; 23(1):30-8. PubMed ID: 21210876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
    Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
    J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasminogen activator inhibitor type 1 (PAI-1) in blood and tissue extracts of patients with non-small cell lung cancer].
    Zekanowska E; Cieśliński K; Rość D
    Pneumonol Alergol Pol; 2004; 72(9-10):409-14. PubMed ID: 16021996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W; Izycki T; Ossolinska M; Chyczewska E
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.